|
|
6340 Sequence Drive
San Diego, CA 92121 USA
phone:858.200.0200
fax:858.200.0201
|
|
| Symbol |
DXCM |
| Exchange |
Nasdaq |
| Founded |
1999 |
| Employees |
233 |
|
|
| www.dexcom.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Continuous glucose monitoring system for diabetic patients |
|
| Management |
| Terrance H. Gregg, President and CEO; Steven R. Pacelli, Chief Administrative Officer; Andrew K. Balo, Senior Vice President of Clinical & Regulatory Affairs and Quality Assurance; Peter Gerhardsson, Vice President of International Business Development; Richard Doubleday, Vice President of Sales |
| |
|
|
|
|
|
|
|
| Keywords |
| blindfolded, platinum-based, water-resistant, frustration, lightweight |
|
|
|
| Description |
|
DexCom, Inc., a development stage medical device company, engages in the design and development of continuous glucose monitoring systems for diabetics. The company has developed a short term continuous glucose monitoring system, the DexCom STS System, which includes the STS Sensor, the STS Transmitter, and the STS Receiver. |
|
| Products / Services |
DexCom is developing two platforms of continuous glucose monitoring, a long term and a short term system.
|
|
| Technology / Differentiation |
| The tiny probe-like STS Sensor is inserted by the patient under the skin, and is held in place by an adhesive. Once inserted, the STS Sensor begins continuously monitoring glucose. The STS Transmitter sends the glucose signal from the STS Sensor and wirelessly transmits the data to the hand-held STS Receiver. The STS Receiver processes the glucose signal and with the push of a button, the Receiver displays the patient's current glucose value, as well as 1-hr, 3-hr, and 9-hr trends. The Receiver also sounds an alert when a high or low glucose reading is detected. |
|
| Market / Customers |
20 million people in the U.S. have diabetes, according to the Center for Disease Control. DexCom's device is designed to help people with diabetes more conveniently and effectively manage their blood sugar levels.
|
|
| Status |
| In March 2006, DexCom received FDA approval for its STS Continuous Glucose Monitoring System. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members